1. Home
  2. List
Reference Patent

Reference - List

  • 501 Hits
  • Search Condition : Filter (MeSH = Antineoplastic Agents / pharmacology*)
Species Resource Title
Human and Animal Cells Hep G2 Phosphorylation of mTOR Ser2481 is a key target limiting the efficacy of rapalogs for treating hepatocellular carcinoma.
Human and Animal Cells 1B2C6(RCB0795) , 1C3D3(RCB0796) , MIA Paca2(RCB0294) , OS-RC-2(RCB0735) , MG-63(RCB1890) , Saos-2(RCB0428) , K562(RCB0027) , A431 , Hep G2 , A549 , ... Identification of Dihydroorotate Dehydrogenase Inhibitors─Indoluidins─That Inhibit Cancer Cell Growth.
Human and Animal Cells B16 melanoma 4A5(RCB0557) Lignan dicarboxylates and terpenoids from the flower buds of Cananga odorata and their inhibitory effects on melanogenesis.
Human and Animal Cells YSCCC(RCB1549) , HuCCT1(RCB1960) , RBE(RCB1292) , SSP-25(RCB1292) Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.
Human and Animal Cells HCT116(RCB2979) , Colon-26(RCB2657) Specific inhibition of oncogenic RAS using cell-permeable RAS-binding domains.
Human and Animal Cells SK-MEL-28(RCB1930) Depolarization potentiates TRAIL-induced apoptosis in human melanoma cells: role for ATP-sensitive K+ channels and endoplasmic reticulum stress.
Human and Animal Cells WI-38(RCB0702) Cytotoxic and apoptosis-inducing activities of triterpene acids from Poria cocos.
Human and Animal Cells A431(RCB0202) Involvement of EGFR in the response of squamous cell carcinoma of the head and neck cell lines to gefitinib.
Human and Animal Cells RCN-H-4(RCB0512) The effect of meloxicam, a selective COX-2 inhibitor, on the microvasculature of small metastatic liver tumors in rats.
Human and Animal Cells SQ-5(RCB0110) Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate-dehydrogenase-release assay.
Human and Animal Cells MOLT-4(RCB0206) , SKW-3(RCB1168) Drug resistance to nelarabine in leukemia cell lines might be caused by reduced expression of deoxycytidine kinase through epigenetic mechanisms.
Human and Animal Cells Lu-134-A(RCB0466) , Lu-134-B(RCB0467) Targeting small cell lung cancer harboring PIK3CA mutation with a selective oral PI3K inhibitor PF-4989216.
Human and Animal Cells WEHI-3(RCB0035) , Ba/F3(RCB0805) Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells.
Human and Animal Cells MKN45(RCB1001) Excessive MET signaling causes acquired resistance and addiction to MET inhibitors in the MKN45 gastric cancer cell line.
Human and Animal Cells COLO-320(RCB1193) , LoVo(RCB1639) Tumor suppressor miR-193a-3p enhances efficacy of BRAF/MEK inhibitors in BRAF-mutated colorectal cancer.
Human and Animal Cells K562(RCB1897) Cytotoxic and Antiproliferative Effects of Diarylheptanoids Isolated from Curcuma comosa Rhizomes on Leukaemic Cells.
Human and Animal Cells PC-3(RCB2145) A Novel Prodrug of a γ-Glutamylcyclotransferase Inhibitor Suppresses Cancer Cell Proliferation in vitro and Inhibits Tumor Growth in a Xenograft Mouse Model of Prostate Cancer.
Human and Animal Cells U251(RCB0461) Antitumor activity of a novel antisense oligonucleotide against Akt1.
Human and Animal Cells TCS(RCB0638) Anti-progressive effect of neutral endopeptidase 24.11 (NEP/CD10) on cervical carcinoma in vitro and in vivo.
Human and Animal Cells Hep G2 The soluble form of human leukocyte antigen class I antigen causes apoptosis on hepatocellular carcinoma cell lines.